Catalyst Wire Dossier Catalyst Wire Dossier

INXN-3001

· Alaunos Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INXN-3001, covering 2013-07-18 to 2013-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma [Phase 1]

See pricing